This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Read our cookie policy.
Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Chief Development Officer
Fresenius Medical Care North America
As chief development officer, Brian Gauger is responsible for corporate mergers and acquisitions across North America, leading scores of successful business development transactions. In addition, in 2017 Brian was named chief executive officer and president of National Cardiovascular Partners, LLP, an innovative company that creates, sustains, and grows independent, outpatient cardiac catheterization and vascular labs. In that role, Brian is responsible for guiding the organization's overall direction, strategy, and partnership development efforts. Further, in 2018, Brian became responsible for the oversight of corporate strategy for FMCNA.
Prior to joining FMCNA, Brian built twenty-two years of experience in the dialysis industry, with executive roles in sales, marketing, and business development.
© 2006-2020, Fresenius Medical Care, All Rights Reserved